At WWDC 2026 Apple redesigned its Health app and rebuilt its heart-rate engine, but delayed Project Mulberry, its rumored AI health coach, saying it wanted more reliable biometric data first, even as Google's Gemini Health Coach already shipped in May.
Withings' Body Scan 2, on sale in the US since July 2026 for $599.95, reads more than 90 biomarkers to flag hypertension, pre-diabetes and heart rhythm problems, part of a broader company push into reimbursed clinical care.
Recursion Pharmaceuticals says REC-4881, a drug its AI platform found through unbiased cell-imaging screens rather than a predetermined target, cut polyp burden by more than half in patients with familial adenomatous polyposis, a disease with no approved drug treatment.
George Mason University's Injury Analytics Lab has patented an AI system that adjusts imaging to skin tone and combines it with electronic health record data to detect and assess bruises more consistently, aiming to close a long-documented equity gap in injury detection.
Generate:Biomedicines has launched two global Phase III trials for GB-0895, an AI-engineered antibody for severe asthma dosed just twice a year, testing whether machine-designed biologics can clear the same bar as conventionally discovered drugs.
Twelve major US health systems, together caring for nearly 20 million patients a year, have joined Aidoc to form a Diagnostic AI Consortium aimed at building shared standards for how diagnostic AI is evaluated and governed across hospitals.
Garmin's new Connect+ subscription bundles an AI feature called Active Intelligence, built on decades-old Firstbeat physiological modeling, alongside CES 2026's AI food-photo tracking, testing how far a hardware-first brand can push into paid AI coaching.
Samsung and Massachusetts General Hospital's Diabetes Research Center are testing whether Galaxy Watch8 sensors and AI-guided coaching can help patients on GLP-1 drugs preserve muscle mass, validating wearable data against clinical DXA scans.
Samsung's June 2026 Samsung Health overhaul adds four AI-driven metrics, Vitals, Heart Health Score, Daily Cardio Load and Fitness Index, to the Galaxy Watch, aiming to flag real problems instead of flooding wearers with data.
Abbott and Google unveiled a partnership on August 11, 2026 integrating Lingo glucose sensor data with Google's AI Health Coach, targeting 115 million Americans with prediabetes and launching one of the largest real-world metabolic health studies to date.